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Abstract
Background: The Gastrointestinal (GI) tract is critical to AIDS pathogenesis as it is the primary site for viral transmission and
a major site of viral replication and CD4
+ T cell destruction. Consequently GI disease, a major complication of HIV/SIV
infection can facilitate translocation of lumenal bacterial products causing localized/systemic immune activation leading to
AIDS progression.
Methodology/Principal Findings: To better understand the molecular mechanisms underlying GI disease we analyzed
global gene expression profiles sequentially in the intestine of the same animals prior to and at 21 and 90d post SIV
infection (PI). More importantly we maximized information gathering by examining distinct mucosal components
(intraepithelial lymphocytes, lamina propria leukocytes [LPL], epithelium and fibrovascular stroma) separately. The use of
sequential intestinal resections combined with focused examination of distinct mucosal compartments represents novel
approaches not previously attempted. Here we report data pertaining to the LPL. A significant increase (61.7-fold) in
immune defense/inflammation, cell adhesion/migration, cell signaling, transcription and cell division/differentiation genes
were observed at 21 and 90d PI. Genes associated with the JAK-STAT pathway (IL21, IL12R, STAT5A, IL10, SOCS1) and T-cell
activation (NFATc1, CDK6, Gelsolin, Moesin) were notably upregulated at 21d PI. Markedly downregulated genes at 21d PI
included IL17D/IL27 and IL28B/IFNc3 (anti-HIV/viral), activation induced cytidine deaminase (B-cell function) and
approximately 57 genes regulating oxidative phosphorylation, a critical metabolic shift associated with T-cell activation.
The 90d transcriptome revealed further augmentation of inflammation (CXCL11, chitinase-1, JNK3), immune activation
(CD38, semaphorin7A, CD109), B-cell dysfunction (CD70), intestinal microbial translocation (Lipopolysaccharide binding
protein) and mitochondrial antiviral signaling (NLRX1) genes. Reduced expression of CD28, CD4, CD86, CD93, NFATc1 (T-
cells), TLR8, IL8, CCL18, DECTIN1 (macrophages), HLA-DOA and GPR183 (B-cells) at 90d PI suggests further deterioration of
overall immune function.
Conclusions/Significance: The reported transcriptional signatures provide significant new details on the molecular
pathology of HIV/SIV induced GI disease and provide new opportunity for future investigation.
Citation: Mohan M, Kaushal D, Aye PP, Alvarez X, Veazey RS, et al. (2012) Focused Examination of the Intestinal lamina Propria Yields Greater Molecular Insight
into Mechanisms Underlying SIV Induced Immune Dysfunction. PLoS ONE 7(4): e34561. doi:10.1371/journal.pone.0034561
Editor: Jan-Hendrik Niess, Ulm University, Germany
Received October 9, 2011; Accepted March 5, 2012; Published April 12, 2012
Copyright:  2012 Mohan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Supported by National Institutes of Health grants: DK083929, DK50550, RR00164, and RR16930. The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: alackner@tulane.edu
Introduction
Human immunodeficiency virus (HIV) and simian immunodefi-
ciency virus (SIV) infections are characterized by continuous CD4
+
T cell destruction, chronic immune activation and increased
susceptibility to opportunistic infections that are easily controlled
by healthy individuals [1]. The gastrointestinal immune system, in
particular, is an important target of HIV/SIV as it is not only the
largest immunologic organ but also a major site for viral replication
and CD4
+ T cell destruction (as early as 21 days post infection) [2–
6]. The loss of CD4
+ T cells from the GI immune system is often
associated with significant pathological alterations in GI structure
and function [7–9]. The GI pathology, characterized by chronic
persistent inflammation and a variety of histopathological abnor-
malities [7–8], is believed to set the stage for pathological events that
lead to AIDS progression [10]. More specifically, breakdown of the
intestinal epithelial cell barrier, a common occurrence in intestinal
disease, was shown to facilitate translocation of intestinal lumenal
bacteria and their products into the systemic circulation leading to
chronic activation of the immune system and progression to AIDS
[10]. While the exact chronological events that lead to intestinal
epithelialbarrierdisruptionremaintobedetermined,itisreasonable
to assume that inflammatory cell infiltration in the lamina propria
[7] and subsequent proinflammatory cytokine production [11] in
response to viral replication can indirectly affect epithelial cell
function including alterations in epithelial cell permeability.
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34561Based on our earlier studies, the occurrence of GI disease in
SIV-infected rhesus macaques is associated with constitutive
activation of the JAK-STAT pathway (Janus Kinase-Signal
Transducer and Activator of Transcription). More specifically,
GI disease in SIV-infected rhesus macaques was accompanied by
increases in IL-6 mRNA, constitutive activation of p-STAT3 and
increases in SOCS-3 mRNA [12]. Expression of p-STAT3 was
localized to CD68 expressing macrophages and scattered CD3
+
lymphocytes in the GI tract of SIV-infected rhesus macaques with
chronic diarrhea [12]. In a follow up study, we also found
significant increases in the expression of C/EBPb, a proinflam-
matory transcription factor, in the GI tract of SIV-infected
macaques [13]. In addition to being proinflammatory, C/EBPb
has been shown to enhance viral replication. More strikingly, we
observed GI inflammation and disease in 70% (7/10) of macaques
that did not have any opportunistic infections suggesting that the
effects could be attributable to SIV. Further the data also indicated
an association between persistent GI inflammation and increased
mucosal viral loads which was reflected by increased binding of C/
EBPb and p65 to the SIV LTR (long terminal repeat) in lamina
propria leukocytes (LPLs) isolated from the colon [13]. In addition
to our studies, molecular pathological changes in GI function in
response to HIV/SIV during acute and chronic infection have
been also been described by others in detail [14–18].
While dissecting individual pro-inflammatory signal transduc-
tion mechanisms can provide detailed insight into the molecular
pathology, the very nature of these studies can make the entire
process less efficient and time consuming. An alternative and a
more efficient approach is to obtain expression profiles either at
the mRNA or protein level on a genome wide scale and then focus
subsequent research efforts on key molecules/signaling pathways
of interest. In more recent years, the application of functional
genomics approaches to GI tract biopsies from HIV-infected
individuals and SIV-infected rhesus macaques has revealed
significant reduction in the expression of genes regulating cell
cycle, lipid metabolism, epithelial cell barrier and digestive
functions [14–15]. Although these studies contributed significant
molecular insights into AIDS pathogenesis we strongly believe that
the quantity and quality of information obtainable from any high
throughput approach can be profoundly increased and further
expanded if complexity of tissue samples can be addressed. The
intestinal wall can be divided into several functional and anatomic
components with the key events in AIDS pathogenesis occurring
in the mucosa. The mucosa can be further subdivided into 1)
intestinal epithelial cells, 2) intraepithelial leukocytes (IELs), 3)
lamina propria leukocytes (LPLs) and 4) fibrovascular stroma.
Both SIV and HIV infection are known to cause massive loss of
intestinal CD4
+ T cells that reside primarily in the lamina propria
[2–6]. This marked population shift causes marked changes in
gene expression, which would obscure changes in other compo-
nents of the intestine. In order to make the starting material less
complex and maximize specificity and sensitivity of information
gathering we have separated the different cellular/structural
components of the intestine (epithelium, IELs, LPLs, fibrovascular
stroma., etc) and analyzed gene expression in each component
separately. From the pathogenesis perspective, this novel approach
creates a unique opportunity to investigate and better understand
the intricate relationship between viral replication, the host
immune system and damage to the structural and functional
components of the intestine. To accomplish this we obtained serial
intestinal resections prior to infection and at 21 and 90d PI from
the same set of animals. This allowed each animal to be its own
control further enhancing the quality of the data. The time points
chosen were selected as they represent the nadir of CD4
+ T cell
depletion (peak viremia is at 14 d PI but peak mucosal CD4
+ T cell
loss is a week later) and establishment of viral set point. Using this
novel combinatorial approach we have identified unique tran-
scriptional signatures related to key pathogenic events such as
immune activation, inflammation, epithelial barrier disruption
(intestinal microbial translocation), immune cell dysfunction and
mitochondrial anti-viral signaling in intestinal LPLs at 21 (acute)
and 90 (chronic) d PI.
Results
Viral load and depletion of mucosal CD4+ T cells
Infection of rhesus macaques with SIV results in high acute
plasma viral loads and rapid depletion of mucosal CD4
+ T cells
[2–6]. Consistent with these prior observations the animals used in
this study had high viral loads (Fig. 1A) and a rapid and profound
depletion of intestinal CD4
+ T cells with a nadir at 21d after
infection (Fig. 1B). Figure 1C further shows that the loss of CD4
+
T cells was primarily due to depletion of the ‘‘memory’’ population
that is CD45RA negative and CCR5 positive. The loss of mucosal
CD4
+ T cells was accompanied by a concomitant increase in
CD8
+ T cells (Fig. 1D) at 21 and 90d PI. Figure S1 shows total B
cell percentages prior to and at 21 and 90d after infection. The
average CD20
+ B cell percentages (dotted line) at 21 and 90d after
infection were not statistically different from the pre-infection time
point.
Gene expression profiles during acute SIV infection in the
LPLs are indicative of early signaling events associated
with immune cell differentiation, activation, expansion,
migration and inflammation
Comparisons in gene expression in the LPLs [enriched for T
and B lymphocytes (70–80%) but with substantial numbers of
macrophages, NK, dendritic and plasma cells] obtained from the
same animals prior to infection and at 21 and 90 days after
infection were performed. Only those transcripts whose expression
either increased or decreased by, at least, 1.7- fold (P#0.05)i n
response to SIV infection were selected and considered differen-
tially expressed.
Following analysis using DAVID [19–20] and GeneCards [21]
we found 409 distinct transcripts to be upregulated in LPLs at 21d
PI (Table 1). In contrast, the number of transcripts whose
expression decreased at this time point was more than two fold
greater (n=858). At the 90 d PI, the number of transcripts with
decreased expression (n=1122) was nearly 3 times greater than
the upregulated transcripts (n=434). The fold difference and p
values for a select number of differentially expressed (up and
down) transcripts at 21 and 90 d PI are shown in tables 2 and 3.
The entire list of differentially expressed genes in acute (21d) and
chronic (90d) infection with their affymetrix IDs, p values and fold
difference can be found in Table S1 and Table S2.
Out of 409 upregulated genes at 21d PI, DAVID identified 363
transcripts to be annotated (Table 1). Using both tools we broadly
classified all differentially expressed genes into 10 different
categories, namely; transcription, immune defense/inflammation,
cell division/differentiation, cell signaling, cell adhesion/migra-
tion, transport, DNA replication/repair, regulation of cellular
cytoskeleton, apoptosis, metabolism and transcripts with unknown
function. The unknown transcripts are not represented in the pie
charts shown in figures 2, 3, 4, 5.
Based on gene ontology/annotation, the 21d time point (the
nadir of CD4
+ T cell loss) yielded several interesting sets of altered
genes. Genes associated with cellular transcription accounted for
,15% (n=55) of differentially expressed genes (Fig. 2). Of
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IL-15, IL-21 signaling), ETS domain transcription factor (macrophage
activation), p300/CBP-associated factor (PCAF) associated factor (histone
acetylase), aryl hydrocarbon receptor nuclear translocator (AHRNT)
(immunosuppressant), estrogen receptor b (B cell activation), Myocardin,
Nuclear receptor subfamily 6 (Co-repressor), group A, and v-maf
(musculoaponeurotic fibrosarcoma oncogene) (coactivator).
Immune defense/inflammation and Cell division/differentia-
tion accounted for ,7% (n=26) of the upregulated genes (Fig. 2).
Prominent members in the immune defense/inflammation
category included C-type lectin domain family 7, member A (DECTIN1),
Toll-like receptor adaptor molecule (TRIF/TRAM), Complement component
1, s subcomponent, inhibitor of kappa light polypeptide gene enhancer in B-cells
epsilon (IkBKE, a corepressor), interleukin 10 (IL-10) (anti-inflammatory),
interleukin 12 receptor, beta 2 (IL-12Rb2) (Th1 response and proin-
flammatory) and interleukin 21 (IL-21) (proinflammatory). Notable genes
regulating cell division/differentiation (6%, n=23) included
CDK6, platelet derived growth factor beta polypeptide, oncostatin M precursor
(OSM), cardiotrophin-like factor 1 (B cell activation), BMP6, TGF-b2 and
TGF-b3 (cell differentiation).
Approximately, 11% of the transcripts included cell signaling
genes (n=22) such as EGFR, FGF-11, TNF receptor associated factor 4
isoform 1, v-akt murine thymoma viral oncogene homolog 2, suppressor of
cytokine signaling 1 (SOCS1 (Negative regulator of JAK-STAT pathway).
Another 7% included genes associated with cell adhesion/
migration (n=27) that included catenin, dystroglycan 1, integrin alpha
L (leukocyte recruitment/trafficking), platelet/endothelial cell adhesion
molecule (CD31 antigen) (leukocyte recruitment/trafficking), and mucin 5B.
Figure 1. SIV infection results in elevated plasma viremia and rapid depletion of mucosal CD4+ T cells. Plasma viral loads (A) and
changes in mucosal CD4+ T cells (B) ‘‘memory’’ CD4
+ T cells (CD45RAneg, CCR5+) (C), and mucosal CD8
+ T cells (D) in three Indian origin rhesus
macaques at 21 and 90 days after intravenous infection with SIVmac251. Changes in CD45RA+/CCR52 populations at the 21 and 90d timepoints
were not statistically significant (p.0.05).
doi:10.1371/journal.pone.0034561.g001
Table 1. Differentially expressed genes in lamina propria leukocytes (LPLs) during acute (21d PI) and chronic (90d PI) SIV infection.
Up regulated Known Unknown Annotated genes*
21 D PI 409 363 46 363
90 D PI 434 355 79 351
Down regulated Known Unknown Annotated genes
21 D PI 858 795 63 752
90 D PI 1122 938 134 910
*The numbers under the columns titled ‘‘Known’’ and ‘‘Annotated genes’’ differ as some of the annotated genes are represented by multiple probes.
doi:10.1371/journal.pone.0034561.t001
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Gene ID Symbol Fold Difference P value
Up vs Preinfection
Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 NFATc1 2.0 0.003
Signal Transducer and activator of Transcription 5A STAT5A 2.8 0.008
E74-like factor 3 (ETS domain transcription factor) ELF3 1.8 0.049
TAF5-like RNA polymerase II/P300/CBP-associated factor TAF5L/PCAF 2.2 0.03
Aryl hydrocarbon receptor nuclear translocator AHRNT 2.2 0.04
Estrogen receptor beta ESR2 2.2 0.04
Myocardin MYOCD 1.8 0.02
Nuclear receptor subfamily 6 group A NR6A1 1.9 0.02
v-maf masculoaponeurotic fibrosarcoma oncogene MAF 2.3 0.03
C-type lectin domain family 7, member A CLEC7A 2.3 0.03
Toll-like receptor adaptor molecule TICAM2 3.3 0.03
Complement component 1, s subcomponenet C1S 5.2 0.04
Inhibitor of kappa light polypeptide gene enhancer in B cells epsilon IkBKE 2.9 0.0008
Interleukin 10 IL10 2.4 0.02
Interleukin 12 receptor, beta 2 IL12Rb2 2.8 0.03
Interleukin 21 IL21 1.9 0.04
Suppressor of cytokine signaling 1 SOCS1 1.9 0.02
Basement membrane-induced gene ICB1/C1orf38 2.4 0.01
FYN binding protein FYB 2.2 0.028
Arachidonate 5-lipoxygenase ALOX5 4.0 0.002
CD6 antigen CD6 3.2 0.02
Cyclin Dependant kinase 6 CDK6 2.4 0.04
Platelet derived growth factor beta polypeptide PDGFb 2.5 0.006
Oncostatin M precursor OSM 2.8 0.01
Cardiotrophin-like factor 1 CTLF-1 3.8 0.01
Bone morphogenic protein 6 BMP6 2.6 0.02
Transforming growth factor beta 2 TGFb2 2.0 0.03
Transforming growth factor beta 3 TGFb3 2.4 0.02
Epidermal growth factor receptor EGFR 1.8 0.02
Fibroblast growth factor 11 FGF11 3.0 0.04
Tumor necrosis factor receptor associated factor 4 isoform 1 TRAF4 2.5 0.02
v-akt murine thymoma viral oncogene homolog 2 AKT2 1.8 0.02
Catenin CTNND1 2.1 0.008
Dystroglycan 1 DAG1 2.6 0.02
Integrin alpha L ITGAL 1.8 0.02
Platelet/endothelial cell adhesion molecule (CD31) PECAM-1 2.3 0.01
Mucin 5B MUC5B 2.8 0.02
Gelsolin GSN 5.7 0.02
Moesin MSN 1.7 0.004
TBC1 domain family member 10A TBC1D10A 1.8 0.03
Down vs Preinfection
Interleukin 17D or Interleukin 27 Il17D 1.8 0.04
Interleukin 28B IL28B 2.0 0.04
CCAAT-enhancer binding protein alpha C/EBPa 2.2 0.02
Activation induced cytidine deaminase AID 2.0 0.01
Peroxiredoxin 2 PRDX2/NKEFB 3.2 0.03
Granzyme K GZMK 2.0 0.02
Interleukin 17 receptor E isoform 1 IL17RE 2.0 0.004
programmed cell death 2 PDCD2 2.0 0.04
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cellular cytoskeleton (gelsolin, Moesin, TBC1 domain family member
10A, actinin, and alpha 4 smooth muscle myosin heavy chain 11 isoform
SM1A). The remaining transcripts fell into the following functional
categories: metabolism (10%, n=38), cellular transport (8%,
n=28), Apoptosis (1%, n= 3), DNA replication/repair (1%, n=
3), and translation (4%, n=13) (Fig. 2).
In addition, compared to the 90d PI time point, the 21 day
timepoint had increased expression of several genes associated with
cell adhesion/migration [CD93, cell adhesion molecule 1, intercellular
adhesion molecule 1 (ICAM1), lectin galactoside-binding soluble 3]a n d
immune defense/inflammation [CD4, CD40 ligand, Chemokine (C-C
motif) ligand 3 (CCL3), Chemokine (C-X-C motif) ligand 1 (CXCL1),
interleukin 18 (IL-18), tumor necrosis factor receptor superfamily, member 10b
(tnfrsf10b), tumor necrosis factor, alpha-induced protein 2, HLA class II
histocompatibility antigen, DM beta chain precursor (MHC class II antigen
DMB), CD68, ATP-dependant helicase LGP2, SOCS3, SOCS6].
Collectively, the transcriptional profile presents clear evidence of
increased transcription, inflammatory cytokine signaling, and
metabolic changes associated with immune cell activation including
increased leukocyte trafficking to sites of viral replication/
inflammation. While immune cell activation is required to elicit a
successfulimmune responseagainst an invading pathogen, failureto
moderate this response can cause significant injury to the host.
Consequently, the increased transcription of genes with immuno-
suppressive function like nuclear receptor co-repressor, IkBKE (both
transcriptional inhibitors), IL-10 (an anti-inflammatory cytokine),
SOCS1 (negative regulator of JAK-STAT pathway) and TGF-b1&
2 serve to ensure that these responses are negatively regulated at
multiplestagesandthat the hostisprotectedfrom the adverseeffects
of an exuberant immune response.
Genes encoding proteins linked to oxidative
phosphorylation and antimicrobial/antiviral response are
considerably downregulated in GALT during acute SIV
infection
Interestingly, in contrast to the upregulated genes (n=409)
more than twice as many (n=858) were downregulated at 21d PI
(Table 1). 752 of these downregulated genes were annotated
(Table 1). The exact reasons for this considerable decrease in gene
expression are unclear but could be attributable to the massive
virus induced CD4
+ T cell loss that occurs by 21d PI (Fig. 1B).
More importantly, a greater percentage of the downregulated
transcripts represented genes regulating cellular metabolism (26%,
n=199). Within this category 29% (n=57) were genes connected
to oxidative phosphorylation/citric acid cycle. T cells switch from
oxidative phosphorylation to glycolysis to meet their energy
requirements in response to cellular activation [22]. These findings
are very significant as it provides yet another novel transcriptional
signature indicative of T cell activation as early as 21d PI. Another
noteworthy gene downregulated at the 21 d time point was
peroxiredoxin that may contribute to the antiviral activity of CD8
+
T-cells [23].
Compared to the upregulated group, the percentage of genes
regulating transcription (9%, n=70), cell signaling (6%, n=45),
immune defense/inflammation (3%, n=21), cell adhesion/
migration (2%, n=12), and cell division/differentiation (4%,
n=27) dropped significantly in the downregulated category (Fig. 2
& 3). On the other hand, the percentage of genes representing
translation (8%, n=56), apoptosis (2%, n=15) and DNA
replication/repair (3%, n=21) showed a modest to substantial
increase (Fig. 2 & 3). Percentage of genes regulating cellular
transport and regulation of cellular cytoskeleton remained the
same. Downregulated genes critical to HIV/SIV pathogenesis
include IL-17D, (also known as IL-27) and IL-28B (both anti-viral). IL-
17D has sequence similarity to IL-17 and is produced by Th17
cells [24]. The massive depletion of Th17 cells during acute SIV
infection might explain the reduced expression of its mRNA early
in infection [25]. More importantly, IL-17D or IL-27 inhibits HIV-
1 replication in CD4
+ T cells and macrophages [26]. Similarly, IL-
28B in combination with IL-29 is deemed to be essential for
mounting an efficient antiviral response [27]. Another notable
gene that also displayed decreased expression is C/EBPa,
previously shown to be downregulated by inflammatory cytokine
signaling [28]. These observations suggest that in addition to
immune cell activation, acute SIV infection is also characterized
Table 2. Cont.
Gene ID Symbol Fold Difference P value
programmed cell death 5 PDCD5 1.7 0.03
Up vs 90 d PI
CD93 CD93 2.9 0.003
Cell adhesion molecule 1 CADM1 2.0 0.02
Intercellular adhesion molecule 1 ICAM1 1.7 0.02
Lectin galactose-binding soluble 3 LGALS3 2.0 0.02
CD40 ligand CD40LG 2.8 0.03
Chemokine (C-C motif) ligand 3 CCL3 4.5 0.049
Chemokine (C-X-C motif) ligand 1 CXCL1 4.3 0.00
Interleukin 18 IL18 5.7 0.03
Tumor necrosis factor receptor superfamily, member 10b TNFRSF10B 2.2 0.045
Tumor necrosis factor, alpha-induced protein 2 TNFAIP2 5.0 0.04
HLA class II histocompatibilty antigen, DM beta chain precursor HLA-DMB 3.7 0.047
CD68 CD68 3.4 0.04
Suppressor of cytokine signaling 6 SOCS6 1.8 0.048
doi:10.1371/journal.pone.0034561.t002
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Gene ID Symbol Fold Difference P value
Up vs Preinfection
BCL6 co-repressor BCORL1 2.5 0.04
SMAD6 SMAD6 2.8 0.04
Hepatocyte nuclear factor 4 alpha HNF-4a 2.6 0.03
Chromodomain helicase DNA binding protein 1 CHD1 2.0 0.01
EPH receptor B1 EPHB1 2.1 0.01
Rho GTPase activating protein 1 ARHGAP1 3.3 0.02
Rho/Rac guanine nucleotide exchange factor 2 ARHGEF2 3.9 0.0007
Fibroblast growth factor receptor 1 FGFR1 3.2 0.001
c-jun N terminal kinase 3 JNK3 1.9 0.014
Suppressor of cytokine signaling 1 SOCS1 2.4 0.02
Fc fragment of IgA, receptor for FCAR 1.9 0.03
Microtubule associated serine/threonine kinase 2 MAST2 4.4 0.04
Interleukin 1 receptor-like 1 IL1RL1 2.3 0.01
NLR family, pyrin domain containing 4 NLRP4 2.2 0.02
Nuclear factor of activated T cells 4 NFAT4 3.0 0.02
Tumor necrosis factor ligand superfamily member 7 (CD27 ligand) (CD70 antigen) CD70 6.6 0.017
chemokine (C-X-C motif) ligand 11 CXCL11 2.4 0.003
Chitinase 1 CHIT1 4.0 0.047
CD109 CD109 1.8 0.026
Semaphorin 7A SEMA7A 3.4 0.0006
Complement factor H CFH 1.8 0.03
Lipopolysaccharide binding protein LBP 5.3 0.02
Defensin beta 119 DEFB119 2.8 0.045
Tissue inhibitor of metallopeptidase 3 TIMP3 2.6 0.046
NLR family member X1 NLRX1 5.5 0.039
Fas-activated serine/threonine kinase FASTK 2.9 0.02
Down vs Preinfection
CD28 molecule CD28 3.9 0.039
CD4 molecule CD4 3.3 0.048
CD59 molecule, complement regulatory protein CD59 2.6 0.005
CD86 molecule CD86 4.5 0.03
CD93 molecule CD93 3.1 0.04
Interleukin 1 receptor IL1R2 3.0 0.003
T cell receptor beta chain V region CTL-L17 TRB@ 2.0 0.005
Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 NFATc1 2.2 0.04
Interleukin 1 receptor associated kinase 3 IRAK3 2.6 0.02
Toll like receptor 8 TLR8 1.9 0.02
Toll like receptor adaptor molecule 2 TICAM2 2.5 0.03
Major histocompatibility complex, class II, DO alpha HLA-DOA 5.5 0.03
Jun dimerization protein p21SNFT BATF3 3.3 0.03
G protein-coupled receptor 183 GPR183 2.9 0.02
HLA class II histocompatibility antigen, DM beta chain HLA-DMB 3.4 0.02
WD repeat domain 36 WDR36 3.7 0.01
Up vs 21 d PI
Alpha defensin 2 DEFA1 2.5 0.019
Coagulation factor II (thrombin) receptor F2R 2.1 0.005
Complement component 8 beta polypeptide C8B 1.9 0.04
Cannabinoid receptor 2 CNR2 2.0 0.039
Thrombospondin 1 THBS1 1.8 0.038
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propria.
Transcriptional profile at viral set point infection is
indicative of intestinal microbial translocation in
conjunction with inflammatory signaling and progressive
immune cell activation and dysfunction
At viral set point (90d PI) a total of 434 genes were found to be
up-regulated (Table 1). Among these 351 were annotated genes
(Table 1). Genes regulating transcription accounted for 14%
(n=47) of those upregulated (Fig. 4). Table 3 shows fold difference
and p values for select transcripts important to HIV/SIV infection.
Of particular interest were (Bcl6 co-repressor (transcriptional repression),
Aryl hydrocarbon receptor nuclear translocator (AHNT) (immunosuppressant),
SMAD6 (anti-inflammatory), STAT5A (IL-2 signaling and T cell
proliferation and clonal expansion), HNF-4a (macrophage activation) and
Chromodomain helicase DNA binding protein 1 (transcriptional activator).
Cell signaling genes comprising EPH receptor B1, Rho GTPase
activating protein 1, Rho/Rac guanine nucleotide exchange factor 2, FGFR1,
MAPK10 or JNK3 (c-jun N terminal kinase3 (pro-inflammatory), CD109
(negative regulation of TGFb signaling), SOCS1 (negative regulator of JAK-
STAT pathway) comprised ,13% (n=48) of the upregulated genes
(Fig. 4). Interestingly, several of the GTP binding proteins (Rho
GTPase activating protein 1, Rho/Rac guanine nucleotide exchange factor 2)
that play important roles in T cell activation are target genes
induced by STAT5A, a downstream transcription factor activated
by IL-2 signaling [29] which was also up-regulated during acute
and chronic infection.
Approximately, 7% (n=25) of the genes represented immune
defense and inflammation. Notable genes were CD38, CD70,
CXCL11, chitinase1 (all 4 proinflammatory), semaphorin 7A, complement
factor H, lipopolysaccharide binding protein (LBP) (proinflammatory),
NLRX1 (negative regulator of mitochondrial anti-viral signaling), defensin
beta (anti-microbial) and tissue inhibitor of metallopeptidase 3 (anti-
inflammatory) (Fig. 4). Semaphorin 7A (CD108) expressed on
activated T cells has been shown to stimulate proinflammatory
cytokine production in monocytes and macrophages via binding to
a1b1 integrin (very late antigen-1) and is believed to be a
mechanism by which effector T cells induce persistent inflamma-
tion through macrophage activation [30].
We chose CD70 and CXCL11 for further confirmation studies
using real-time RT-PCR because of their importance to HIV/SIV
pathogenesis. CD70 has been previously linked to B cell
dysfunction [31–32] and CXCL11 also known as interferon
gamma inducible T cell alpha chemoattractant (ITAC) is a major
chemokine shown to be produced by HIV infected macrophages
for the recruitment of CCR5/CD4
+ positive T cells as these cells
also express CXCR3 (receptor for CXCL11) [33]. As shown in
figure 6, quantitative real-time RT-PCR confirmed a statistically
significant increase in the expression of CD70 (6 months post SIV
infection) and CXCL11 (90d and at 6 months post SIV infection)
in the lamina propria cellular compartment.
The remaining genes fell into the following categories: cell
adhesion/migration (5%, n=18), cellular transport (7%, n=26),
cell division/differentiation (3%, n=10) regulation of cellular
cytoskeleton (3%, n=11), apoptosis (2%, n=7), translation (2%,
n=8) and DNA replication/repair (1%, n=4). Among the
apoptotic genes Fas-activated serine/threonine kinase is striking, as it
is a strong inducer of lymphocyte apoptosis [34].
In comparison to the 21d time point, several interesting genes
associated with immune defense/inflammation (alpha defensin 2,
coagulation factor II (thrombin) receptor, complement component 8 beta
polypeptide, cannabinoid receptor 2 (macrophage), cell adhesion/migration
(thrombospondin 1) and cell signaling (CD38, also an immune
activation marker) showed enhanced expression at the 90d time point
post SIV infection.
Two other upregulated genes, namely, SMAD6 [35] and
SOCS1 [36] are well established negative regulators of TGFb/
BMP and JAK-STAT pathways, respectively. In addition,
SMAD6 also serves an anti-inflammatory function by interacting
with the adaptor protein pellino-1 [37]. This may be viewed as a
protective response to offset the increased expression of genes
associated with inflammation and immune activation. While
negative regulation is necessary to prevent uncontrolled cell
signaling, paradoxically, the latter response could prove counter-
productive to the host as it dampens the host’s immune response to
continuing viral replication, especially, by inhibiting anti-viral
signaling by IFNc [36].
Genes associated with T cell signaling and innate
immune responses are downregulated suggesting,
immune cell exhaustion and dysfunction by 90 days post
SIV infection
The 90d time point witnessed the maximum number of
downregulated genes (1122 genes). Most of the downregulated
genes fell into three categories: Metabolism (18%, n=165),
transcription (13%, n=120), and cell signaling (10%, n=92).
The rest of the genes fell into the following categories: cellular
transport (8%, n=76), immune defense/inflammation (6%,
n=56), cell division/differentiation (4%, n=39), cell adhesion/
migration (4%, n=38), regulation of cellular cytoskeleton (2%,
n=22), translation (3%, n=23), DNA replication/repair (2%,
n=14) and apoptosis (2%, n=20) (Fig. 5).
Interestingly, a considerable number of downregulated genes
were associated with T cell signaling and activation such as CD28,
CD4, CD59, CD86, CD93, T-cell receptor beta chain V region CTL-L17,
NFATc1 and innate immune responses such as Toll-like receptor
(TLR) signaling (IRAK3, TLR8, Toll like receptor adaptor molecule 2),
major histocompatibility complex-DO alpha, interleukin 1 receptor, including
the proinflammatory/anti-HIV neutrophil chemoattractant IL-8.
Together with the decline in CD4
+ T cell numbers, the
downregulation of TLR8, IL-8 and HLA-DOA expressed on
macrophages/dendritic cells and B cells, respectively, suggests
generalized immune dysfunction that can in due course lead to
immune exhaustion.
Discussion
The intestine is a complex organ with multiple functional and
structural elements made up of diverse cell types that closely
Table 3. Cont.
Gene ID Symbol Fold Difference P value
CD38 CD38 1.8 0.015
doi:10.1371/journal.pone.0034561.t003
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34561Figure 2. Gene functional categories up (1.7 fold) in LPLs at 21d PI. The relative size of each sector in the pie chart is determined by the
number of genes in that functional category. Genes with unknown function are not included in the pie chart. Only a few transcripts of importance to
SIV infection are shown in the figure under each functional category. The full list of genes grouped under each functional category for the 21d time
point is provided in Table S1.
doi:10.1371/journal.pone.0034561.g002
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e34561Figure 3. Gene functional categories down (1.7 fold) in LPLs at 21d PI. The relative size of each sector in the pie chart is determined by the
number of genes in that functional category. Genes with unknown function are not included in the pie chart. Only a few transcripts of importance to
SIV infection are shown in the figure under each functional category. The full list of genes grouped under each functional category for the 21d time
point is provided in Table S1.
doi:10.1371/journal.pone.0034561.g003
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PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e34561Figure 4. Gene functional categories up ((1.7 fold) in LPLs at 90d PI. The relative size of each sector in the pie chart is determined by the
number of genes in that functional category. Genes with unknown function are not included in the pie chart. Only a few transcripts of importance to
SIV infection are shown in the figure under each functional category. The full list of genes grouped under each functional category for the 90d time
point is provided in Table S2.
doi:10.1371/journal.pone.0034561.g004
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PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e34561Figure 5. Gene functional categories down (1.7 fold) in LPLs at 90d PI. The relative size of each sector in the pie chart is determined by the
number of genes in that functional category. Genes with unknown function are not included in the pie chart. Only a few transcripts of importance to
SIV infection are shown in the figure under each functional category. The full list of genes grouped under each functional category for the 90d time
point is provided in Table S2.
doi:10.1371/journal.pone.0034561.g005
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single main objective of maintaining homeostasis [38]. Intestinal
homeostasis is drastically altered during HIV/SIV infection as a
result of massive loss of mucosal CD4
+ T cells which then leads to
structural and functional damage [7–9]. This sets the stage for
development of a vicious cycle involving increased epithelial
permeability, microbial translocation, localized inflammation, and
localized and systemic immune activation [10]. Even though
several previous high throughput studies have attempted to
elucidate the molecular mechanisms, successful elucidation of the
initiating and perpetuating mechanisms can be challenging in light
of the marked shifts in cellular populations (loss of CD4
+ T cells)
limited primarily to one compartment (lamina propria) of the
intestine (Fig. 1B&C). Tissue or sample complexity has long been
recognized as a key factor influencing the success of a microarray
experiment [39]. Accordingly, in whole tissues, changes in
expression of key genes can be diluted or neutralized by unequal
contribution of transcripts from multiple tissue compartments or
cell types [39]. Secondly, valuable information can also be lost or
masked due to differential regulation of gene expression within
individual cell populations representing distinct tissue compart-
ments (eg lamina propria vs. epithelium) [39]. As the different
mucosal compartments in the intestine have their own function
and accordingly a different and independent gene expression
profile we have focused on LPLs in this manuscript for the
following reasons. First, the LPLs offer a key line of defense to
invading pathogens and foreign antigens. Second, this compart-
ment contains the largest population of target cells for HIV/SIV
infection [1–2]. Third, this compartment actively participates in
mediating uncontrolled inflammation [12–13] that can lead to
epithelial barrier disruption, a hallmark of untreated HIV/SIV
infection. Fourth, our previous studies on proinflammatory
signaling identified both lymphocytes and macrophages to be the
major cell types associated with dysregulated signaling of the JAK-
STAT3-C/EBPb pathway [12–13]. Using this novel approach,
apart from the broad range of innate immune mechanisms
common to persistent inflammatory conditions our findings
provide significant new clues on the potential mechanisms
underlying critical pathogenic events such as immune cell
activation, B cell dysfunction, microbial translocation, target cell
recruitment and attenuated mitochondrial antiviral signaling.
Acute HIV/SIV infection is accompanied by explosive viral
replication and severe CD4
+ T cell destruction in mucosal tissues,
particularly, GI associated lymphoid tissue (GALT) [2–6].
Interestingly, the critical pathogenic events such as immune cell
activation, differentiation, expansion, migration, and activation of
innate defense responses as well as counterbalancing anti-
inflammatory responses were clearly reflected in the detailed
transcriptional profile we generated from the LPL compartment at
21d PI. Immune cell activation (T, B, macrophages and other
cells) and subsequent proliferation is dependent on increased
transcription of new genes mediated by the activation of specific
transcription factors [40–41]. This is clearly evident from the
significant upregulation of several transcription factors in LPL’s
during acute infection, namely, NFATc1, STAT5A, ESE-1, AHRNT
and ERb. Among these NFATc1 [42] and STAT5A [43], are
known to regulate early processes in T cell activation. Activation of
NFATc1 in response to CD3 and CD28 co-stimulation is required
for T cells to execute their effector functions including transcrip-
tion of the IL-2 gene that controls most of the early lymphocyte
proliferative responses [44]. Signaling via STAT5A, a downstream
transcription factor activated by IL-2, IL-12, IL-15 and IL-21, is
required for cell cycle progression and clonal expansion of T cells
[43]. Similarly, E74 like factor-3 or ESE-1, an ETS domain
transcription factor with, at least, 30 members is induced in cells of
the monocyte-macrophage lineage in response to inflammatory
cytokines and lipopolysaccharide [45]. Further, ESE-1 has been
shown to enhance the transcription of proinflammatory proteins
such as nitric oxide synthase [46] and angiopoietin [47]. Finally,
ERb is predominantly expressed in B cells and its engagement
promotes B cell activation and survival [48]. The increased
expression of select transcription factors with established roles in
immune function suggests widespread immune activation in
response to a rapidly replicating virus and is consistent with prior
studies [15–17].
Lately, the activation of aryl hydrocarbon receptor (AHR) and
its heterodimeric partner aryl hydrocarbon receptor nuclear
translocator (AHRNT) has been shown to impact anti-viral
immune defenses [49]. AHR activated in response to environ-
mental signals translocates to the nucleus as a receptor-ligand
complex, dimerizes with AHRNT after which the heterodimer
binds to xenobiotic response elements on the DNA and induces
the transcription of genes such as CYP1A1 [49]. Preliminary
evidence from studies using the mouse model of human influenza
A revealed suppressed lymphocyte responses and increased
inflammation in the affected lung in response to AHR activation.
Unfortunately, there is no information available on the role of
AHR and AHRNT in HIV/SIV infection. However, given that
LPS treatment markedly increased AHR and AHRNT mRNA
expression in murine B cells and splenocytes [50], it is possible that
low level LPS translocation from a leaky intestinal epithelial
barrier early in infection might provide the stimulus for AHRT
gene activation. Even though transcription factors for the most
part regulate transcription, this process is largely dependent on the
availability of a transcriptionally permissive chromatin. The
increased expression of p300/CBP-associated factor (PCAF), a histone
acetylase [51], and v-maf, a transcriptional co-activator [52] that
recruits PCAF to the gene promoters satisfies this critical
requirement so that enhanced gene expression during immune
cell activation can be successfully accomplished. Lastly, in addition
to transcription factors, increased expression of gelsolin (actin
Figure 6. CD70 and CXCL11 expression is significantly
increased in the LPLs in chronic SIV infection. Relative abundance
in gene expression for CD70 (light bars) and CXCL11 (dark bars) in the
lamina propria cellular compartment of the jejunum at 90 d (n=3) and
6 months (n=3) post SIV infection detected using quantitative real-time
SYBR green two-step RT-PCR. The fold differences in gene expression
were calculated as described in Materials and Methods. The relative fold
increase is shown on top of each bar graph. The asterisk (*) indicates
statistical significance (p,0.05).
doi:10.1371/journal.pone.0034561.g006
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cytoskeleton) [54], two proteins that play critical roles in regulating
the actin cytoskeleton during T cell activation and polarization
further points toward immune cell activation early in SIV
infection.
Apart from STAT5A, at least, six other differentially expressed
genes, namely, IL-12Rb2, IL-21, IL-10, SOCS-1, cardiotrophin-like
cytokine factor 1 and oncostatin M coupled to the JAK-STAT pathway
were significantly up-regulated in LPL’s during acute infection. IL-
12Rb2 is expressed on activated T cells and is the predominant
receptor that transduces IL-12 signals to effect a Th1 type immune
response by activating STAT4 [55]. Apart from IL-12Rb2,
another gene that showed enhanced expression was IL-21,a
pro-inflammatory cytokine that belongs to the common c-chain-
dependant family of cytokines [56–57]. IL-21 has been shown to
regulate the differentiation and function of effector CD4
+ T helper
cells, promote B cell differentiation and immunoglobulin produc-
tion, and stimulate NK cell and CD8
+ T cell cytotoxic function
[56–57]. Further, IL-21 can inhibit inducible T regulatory cell
(Tregs) differentiation and reduce the ability of CD4
+ T cells to
respond to Treg-induced immunosuppression [56–57]. Further-
more, IL-21 is required for Th17 cell differentiation and stimulates
the expression of matrix degrading metalloproteases by intestinal
fibroblasts and epithelial cells [56–57]. Serum levels of IL-21 are
significantly reduced in HIV-infected individuals early in infection
and positively correlated with CD4
+ T cell counts [58]. Since the
primary source of IL-21 has been reported to be CD4
+ T cells, the
increased expression of this cytokine at this time point is puzzling
and at the same time interesting as intestinal CD4
+ T cells and
Th17 cells are massively depleted as early as 21 d PI [2,25].
Nonetheless, NK cell numbers markedly increase during acute
SIV infection [59] and have been reported to be an alternative
source of IL-21 [60]. The enhanced expression of IL-21 in vivo,i n
the GALT early in infection might serve as a transient immune
enhancing mechanism to restore the massively depleted CD4
+ T
and Th17 cell populations. Other JAK-STAT activating cytokines
such as cardiotrophin like factor 1 can activate B cells [61]. Oncostatin
M has been demonstrated to suppress colitis in DSS treated mouse
models [62]. SOCS proteins negatively regulate the JAK-STAT
pathway and the increased expression of SOCS-1 ensures that
signaling via the JAK-STAT pathway does not remain constitu-
tively active [36]. From these observations it is clear that activation
of the JAK-STAT pathway occurs early in infection and provides
a direct mechanism to stimulate processes such as cell activation,
proliferation and differentiation that are critical to an immune
response.
The success of a rapid inflammatory response is to a great extent
reliant on the host’s capacity to recruit immune/inflammatory
cells to the site of viral replication/insult. Cell adhesion molecules
such as integrin alpha L (CD11a) and PECAM 1 (CD31) play
important roles in leukocyte recruitment via interactions with
endothelial cells [63–64]. The integrin alpha chain (CD11a) in
combination with the beta chain forms the functional CD11a
molecule which serves as a receptor for Intercellular adhesion
molecule 1 and 2 (ICAM) expressed mostly on endothelial cells
[63–64]. Similarly, PECAM-1 expression on leukocytes facilitates
their directional migration along a chemokine gradient to
inflammatory sites [65]. Taken together, the simultaneous up-
regulation of both CD11a and CD31 would suggest the presence of
an active inflammatory response, a process that contributes
directly to immune activation.
Another hallmark of T cell activation is that, naı ¨ve T cells
reprogram their metabolism by switching from oxidative phos-
phorylation (OXPHOS) to glycolysis to meet their increasing
energy demands to carry out various biosynthetic processes [22].
Consistent with this finding, we observed the downregulation of
,57 genes encoding proteins belonging to the OXPHOS
pathway. Unlike C/EBPb, C/EBPa expression is significantly
downregulated by inflammatory cytokines including lipopolysac-
charide [28]. In agreement with the above finding, the decreased
expression of C/EBPa observed in the present study indirectly
indicates activation of inflammatory cytokine signaling in the LPL
during acute SIV infection. Further, we observed significant down-
regulation of two novel molecules with antiviral properties,
namely, IL-17D or IL-27 and IL-28B [26–27]. IL-17D or IL-27
exerts its anti-viral effect by inducing a gene expression profile
similar to that of IFN-a which includes APOBEC3G, an
endogenous anti-viral protein [26]. Similarly, IL-28B was recently
shown to increase granzyme B loading and potentiate CTL killing
function in macaques [66]. To our knowledge, these novel
observations uncovered by minimizing tissue complexity have
not been reported previously in vivo and provide more evidence for
T cell activation and increased susceptibility to GI related
opportunistic pathogens early in infection.
The day 90 time point yielded the maximum number of
differentially expressed genes (n=1556). Similar to the acute stage,
expression of transcription factors, namely, ESE-1, AHRNT and
STAT5A continued to remain elevated during the chronic stage.
Another markedly up-regulated transcription factor, HNF-4a, has
been previously shown to be expressed abundantly by peritoneal
macrophages where it induced the expression of fibroleukin, a
protein linked to the pathogenesis of hepatic failure [67]. The
immune defense/proinflammatory genes, included the ubiquitous
gene encoding for lipopolysaccharide binding protein (LBP), an acute
response protein that is predominantly synthesized by the liver but
also produced by other tissues including the intestine, possibly, by
macrophages in response to the presence of LPS [68]. The finding
is important as it not only provides indirect evidence of intestinal
bacterial translocation but also adds credence to the microbial
translocation theory proposed as a cause of chronic immune
activation that drives progression to AIDS [10]. Interestingly, LPS
also directly induces the expression of ESE-1 [45], AHRNT [50]
and STAT5A [69] which were also elevated. Apart from LBP,
other notable proinflammatory genes showing enhanced expres-
sion were CD38, CD70, CXCL11, chitinase1 and natural cytotoxicity
triggering receptor 2 (NCR2). CD38 is a glycoprotein (ectoenzyme)
expressed on activated T cells and also used as an activation
marker for T cells [70]. Increased numbers of CD8
+CD38
+ T cells
have been reported in chronic infection and coupled to disease
progression in chronic HIV infection [71–72]. Interestingly, the
activation marker density, number and proportion of CD8
+CD38
+
T cells has been shown to positively correlate with viral load in
acute [70] and chronic HIV infection [73]. CD70, also known as
tumor necrosis factor (ligand) superfamily, member 7, is expressed
abundantly on activated T cells of HIV-infected patients [31]. It
has been reported to contribute directly to hypergammaglobulin-
emia in HIV-infected patients by stimulating memory B cells via
CD27 and promoting their differentiation into plasma cells that
subsequently produce elevated levels of immunoglobulin [31].
Overexpression of CD70 in transgenic mice resulted in depletion of
naı ¨ve T cell pools in the spleen and lymph nodes due to their
continuous differentiation into effector T cells via CD70-CD27
interactions [32]. These mice died of penumocystis carinii pneumo-
nia, a hallmark of T cell immunodeficiency even in the absence of
a lentiviral infection [32]. The chemokine, CXCL11 is induced by
interferons in a proinflammatory environment and plays a central
role in recruiting CCR5/CD4
+ T cells to HIV infected antigen
presenting cells (macrophages and dendritic cells) and also their
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elevated expression of CXCL11 (,14-fold) detected at 90 d and 6
months post SIV infection (figure 4) represents a robust host
response that is effectively exploited by the virus to ensure constant
recruitment of target cells to the intestinal lamina propria, a major
site of viral replication.
Similarly, chitinase1 expression is considerably increased in
macrophages in inflamed tissues [74]. Also, NCR2 is expressed
on NK cells and activation of this receptor results in increased
efficiency of NK cell function [75]. Additionally, JNK3, also known
as stress activated protein kinase is a proinflammatory transcription
factor activated by cytokines like TNF-a, IL-1b, growth factors
and a variety of environmental stresses [76]. Its increased
expression is well documented in colonic lamina propria cells of
inflammatory bowel disease patients [77]. Lastly, the identification
of NLRX1, a recently described regulator of mitochondrial
antiviral immunity is yet another important new finding to emerge
from this study. NLRX1 was shown to inhibit anti-viral cytokine
responses mediated through RIG-like helicase family of intracel-
lular receptors and the mitochondrial anti-viral signaling (MAVS)
adaptor [78]. siRNA induced knockdown of NLRX1 promoted
virus-induced type I interferon production and decreased viral
replication [78]. Future studies are definitely required to further
understand the role of NLRX1 in HIV/SIV replication as it has a
high potential to serve as a therapeutic target for decreasing viral
replication. Collectively, the transcriptional signature at viral set
point is suggestive of marked B cell dysfunction, increased
expression of proinflammatory molecules, negative regulation of
anti-viral signaling and widespread T cell activation, most likely, in
response to translocation of intestinal bacteria and bacterial
products.
Gene expression for several components of the T cell signaling
pathway was considerably decreased during chronic infection.
These included CD28, CD4, CD59, CD86, CD93, interleukin 1
receptor, T-cell receptor beta chain V region CTL-L17, NFATc1, and c-type
lectin domain family 2, member B (IFN-alpha-2b-inducing-related protein 1).
Downregulation of CD28 has been previously reported to occur in
lymphoid tissues of HIV-infected patients who progressed to AIDS
[79]. The decreased expression can be directly attributed to a
combination of CD4
+ T cell loss and decreased expression of genes
in immune cells due to a dysfunctional immune response.
Interestingly, several immune mediators expressed exclusively
by macrophages and B cells showed markedly reduced expression
during chronic infection. These included the two pathogen
recognition receptors c-type lectin domain family 7, member A
(DECTIN1), TLR8, their signaling components (IRAK3, TLR8,
Toll like receptor adaptor molecule 2), proinflammatory chemokines IL-8,
CCL18, major histocompatibility complex class II, DO alpha and SOCS-3.
DECTIN1 and TLR8 are pattern recognition receptors that
specifically recognize b-glucans [80] and single stranded RNA on
bacteria/fungi and viruses, respectively [81]. Activation of TLR8,
which is highly expressed on B cells, macrophages and immature
dendritic cells, can suppress HIV-1 replication in lymphoid tissue
of tonsillar origin [82]. Also, IL-8, a chemoattractant for
neutrophils, basophils and T cells, was recently reported to inhibit
HIV replication in PBMCs and ectocervical tissues [83]. While the
mechanisms remain unclear, the downregulation of IL17D or IL-
27 (also downregulated in acute infection) might partially explain
the reduced IL-8 expression observed later in infection. Given the
evidence that IL-17D can stimulate IL-8 production [84], the
continual destruction of Th17 cells throughout SIV infection [25]
might abolish this stimulus leading to reduced IL-8 production by
GALT. Similarly, CCL18, a chemokine also synthesized by
macrophages is a chemoattractant for naive T cells, CD4
+ and
CD8
+ T cells and nonactivated lymphocytes [85]. Further, the
reduced expression of HLA-DOA, a MHC class II molecule
expressed on B cells suggests diminished immune responses
(antigen presentation) during chronic infection [86]. Lastly, the
downregulation of SOCS3 a negative regulator of several cytokines
that activate the JAK-STAT and TLR pathways suggests
dysregulation resulting in constitutive activation of proinflamma-
tory cytokine signaling [36]. On the whole, the reduced expression
suggests continual T cell destruction without reconstitution,
diminished innate immune mechanisms, and markedly dysregu-
lated macrophage and B cell function, the latter well known to be
major features of chronic HIV infection.
In summary, our findings provide significant new knowledge
pertaining to the complex molecular events that unfold in the LPL
compartment of the intestine during acute and chronic SIV
infection. More importantly, minimizing tissue complexity enabled
the successful in vivo identification of interesting transcriptional
signatures associated with key pathogenic events occurring in the
GALT separately at 21 and 90 d post SIV infection. These include
significant new clues to the possible mechanisms underlying B cell
dysfunction (CD70, GPR183, AICDA), T cell activation (CD6,
Semophorin 7A, reduced expression of genes linked to OXPHOS/Citric acid/
TCA cycle), macrophage dysfunction (chitinase, DECTIN1, TLR8,
CCL18, IL8), antiviral signaling/activity (IL17D, IL28B, NLRX1,
CCL3, peroxiredoxin), lymphocyte apoptosis (FASTK) and microbial
translocation (LBP, AHRNT, C/EBPa, ESE-1, STAT5A). Interest-
ingly, the increased expression of ESE-1, STAT5A, AHRNT, LBP
coupled with decreased expression of C/EBPa indirectly suggests
that microbial translocation is occurring early in infection even
though data from peripheral blood show modest evidence of
elevated LPS in circulation. Future studies involving flow
cytometry, in situ hybridization and immunofluorescence are
required to validate the specific cell types in the LPL compartment
of the intestine that express these differentially expressed genes.
This will significantly help streamline future research efforts on key
molecules/signaling pathways of interest to HIV/SIV pathogen-
esis. Similar high throughput studies encompassing the intestinal
epithelium, intraepithelial lymphocytes and fibrovascular stroma
in the immediate future will add additional insight into the
molecular mechanisms underlying GI dysfunction.
Materials and Methods
Ethics statement
All experiments using rhesus macaques were approved by the
Tulane Institutional Animal Care and Use Committee (Protocol
3267-B00). The Tulane National Primate Research Center
(TNPRC) is an Association for Assessment and Accreditation of
Laboratory Animal Care International accredited facility (AAA-
LAC #000594). The NIH Office of Laboratory Animal Welfare
assurance number for the TNPRC is A3071-01. All clinical
procedures, including administration of anesthesia and analgesics,
were carried out under the direction of a laboratory animal
veterinarian. Animals were anesthetized with ketamine hydro-
chloride for blood collection procedures. Intestinal resections were
performed by laboratory animal veterinarians. Animals were pre-
anesthetized with ketamine hydrochloride, acepromazine, and
glycopyrolate, intubated and maintained on a mixture of
isoflurane and oxygen. Buprenorphine was given intra-operatively
and post-operatively for analgesia. All possible measures are taken
to minimize discomfort of all the animals used in this study.
Animals were closely monitored daily following surgery for any
signs of illness such as anorexia, lethargy, diarrhea, vomiting, and
dehydration. Appropriate medical care was implemented if any of
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fatal AIDS-like disease after infection with SIV. If euthanasia was
required in the judgment of the TNPRC veterinary staff, animals
were euthanized in accordance with the recommendations of the
panel on Euthanasia of the American Veterinary Medical
Association. Tulane University complies with NIH policy on
animal welfare, the Animal Welfare Act, and all other applicable
federal, state and local laws.
Animals and Tissue Collection
Serial resection biopsies (,6–8 cm long) of jejunum were
collected from three Indian-origin rhesus macaques prior to
infection and 21 and 90d after infection with SIVmac251 for
microarray studies. For quantitative RT-PCR studies jejunal
tissues from six additional SIV infected macaques and six
uninfected control macaques were also examined.
Cell isolation from Intestinal resection segments
In order to determine the impact of high viral replication and
massive CD4
+ T cell loss on the intestinal mucosa we conducted a
longitudinal study to assess genome wide changes in gene
expression profiles during SIV infection using Affymetrix (Santa
Clara, CA) rhesus macaque arrays that contain about 54,675
capture probes. To minimize information loss and to make the
starting material less complex we separated the intestinal epithelial
cells from the underlying LPLs and fibrovascular stroma. Finally,
the intra epithelial cells (IELs) were separated from the epithelial
cells and changes in gene expression were analyzed in all 4
compartments separately. In order to successfully separate all 4
tissue compartments and ensure the availability of sufficient
starting material we obtained intestinal resection segments (6–
8 cm long) from the jejunum instead of pinch biopsies. To
prioritize our efforts we have in the present communication
focused on the changes occurring in the LPLs at 21 and 90 days
after SIV infection. Comparisons in gene expression were made to
resection segments collected from the same animal 6 weeks prior
to SIV infection. While profiling gene expression in a single cell is
the gold standard, performing such an analysis on the intestine can
be a very painstaking process due to the fact that the intestine in its
entirety comprises, at least, 20–25 different cell types. Accordingly,
while the LPLs are enriched for lymphocytes (70–80%); this
population also contains small numbers of macrophages, dendritic
and plasma cells.
Briefly, surgical resection segments (6–8 cm long) for mRNA
profiling studies were first incubated with vigorous shaking in
Ca
++Mg
++ free-HBSS containing 1 mM EDTA for two 30-min
incubations at 37uC to separate the intestinal epithelial cells [2,87].
Following incubation, the epithelial cells in the supernatant were
harvested by centrifugation at 500 g for 10 min followed by
subjecting the cells to percoll density gradient centrifugation to
separate IELs [2,87]. After dislodging the epithelial cells the tissue
segments were incubated twice for 30 minutes duration in
RPMI1640 containing 20 U of collagenase per ml while rapidly
shaking at 37uC to separate LPLs from the fibrovascular stroma
[2,87]. The tissue homogenates were subjected again to percoll
density gradient centrifugation to separate LPLs from the
fibrovascular stroma. The purified components were then used
for flow cytometry and microarray hybridization as indicated
below.
For quantitative RT-PCR confirmation studies described below,
jejunal tissues from six SIV infected macaques (3 animals at 90d PI
and 3 at 6 months PI) and six uninfected control macaques were
processed similarly except that the tissue homogenates containing
the lamina propria cellular population prepared after collagenase
digestion were not subjected to percoll density gradient centrifu-
gation and instead were used as such for total RNA extraction.
Phenotyping blood and tissue mononuclear cells
Peripheral blood mononuclear cells (PBMCs) were isolated and
processed as previously described [83]. PBMCs were collected by
centrifugation over lymphocyte separation media. Cells (PBMCs
and LPLs) were adjusted to a concentration of 10
7/ml and 100 ml
aliquots (10
6 cells) were stained with appropriately diluted,
directly-conjugated monoclonal antibodies to CD45RA fluoresce-
in isothiocyanate (FITC), CCR5 and CD20 phycoeryrthrin (PE),
CD8-peridinin chlorophyll A protein (PerCP) and CD4-allophy-
cocyanin (APC) (all from BD Biosciences Pharmingen San Diego,
CA). Samples were stained for 30 min in the dark at 4uC, fixed in
2% paraformaldehyde, and stored in the dark at 4uC overnight for
acquisition the next day. Samples were acquired on a LSR II flow
cytometry equipment (BD Biosciences) and analyzed with Flow Jo
software (Treestar Inc, Ashland, OR). Samples were first gated on
lymphocytes by forward and side scatter plots and then on CD4
+
or CD8
+ lymphocytes. Changes in CD45RA
+/CCR5
2 popula-
tions at the 21 and 90d timepoints were analyzed using the
wilcoxon matched-pairs signed rank test.
Microarray Hybridization and Statistical Analysis
Microarray-based profiling of genome wide changes in mRNA
expression in LPL samples was performed using Affymetrix rhesus
monkey GeneChips (U133A 2.0). RNA was isolated from the
three LPL samples derived from intestinal resection seqments
collected at 6 weeks before and at 21 and 90d post-SIV infection.
Total RNA was used to synthesize double-stranded cDNA
(Superscript Choice System; Life Technologies Bethesda Research
Laboratories). The resulting cDNA was purified and used for in
vitro transcription to produce biotin-labeled cRNA (BioArray
HighYield RNA Transcription Labeling kit; Enzo Diagnostics).
The biotinylated cRNA was cleaned (RNAeasy Mini kit; Qiagen),
fragmented, and hybridized on GeneChips containing 54,675
probes sets, using standard protocols at a commercial GeneChip
core facility (). Following three washes, individual GeneChips were
stained with streptavidin-phycoerythrin (Molecular Probes), am-
plified using biotinylated anti-streptavidin (Vector Laboratories),
and scanned for fluorescence (GeneArray Scanner; Hewlett
Packard) measurement on a Microarray Suite 5.0 software
(MAS 5.0; Affymetrix).
For data analysis, the Affymetrix CEL files (containing scanned
images, together with absolute calls for each gene) were transferred
to the S+ statistical module within the Spotfire DecisionSite for
Microarray Analysis (TIBCO-Spotfire) program. Chips were
normalized using the Robust Multichip Analysis (RMA) method,
to stabilize MvA plots. This step was essential to eliminate any
intensity-specific bias in probe-level data and to produce a matrix
comprising of normally distributed data. Expression indices were
reported as log (base 2) of change in gene-expression at either 21d
or 90d time-points, relative to the 0 d baseline. Probe sets whose
targets were not detected were removed from the data matrix. A
Student’s t test was then performed to identify genes expressed in a
statistically significant manner (P,0.05). A fold change cutoff of
$1.7-fold in all three NHPs was then applied, so as to only
consider genes whose expression was perturbed in magnitude and
in a statistically significant manner. The microarray data has been
uploaded to Gene Expression Omnibus and the GEO accession
numbers are GSM846893 through GSM846901.
Gene ontology/annotation analysis was performed using the
DAVID (Database for Annotation, Visualization and Integrated
Discovery) Bioinformatics Functional Annotation tool (http://
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genecards.org/) [21] on all differentially (Up and Down) expressed
transcripts.
Quantitative Real-Time SYBR Green two-Step RT-PCR
Gene expression for CD70 and CXCL11 in the jejunal lamina
propria cellular compartment of two SIV infected macaques was
further evaluated by Quantitative Real-Time SYBR Green Two-
Step RT-PCR assay (QRT-PCR) (ABI, Foster City, CA). Total
RNA was extracted using the miRNeasy kit (Qiagen Inc, Valencia,
CA) and reverse transcribed using the SuperScript. III First-Strand
Synthesis System for RT-PCR kit following the manufacturer’s
protocol. Each QRT-PCR reaction (20 ml) contained the follow-
ing: 26 Power SYBR Green Master Mix without uracil-N-
glycosylase (12.5 ml), target forward and reverse primer (200 nM)
and cDNA (4 ml). Forward and reverse primer sequence for CD70,
CXCL11 and GAPDH is shown in Table 4. The PCR
amplification was carried out in the ABI 7900 HT Fast PCR
System (Applied Biosystems, Foster City, CA). Thermal cycling
conditions were 95uC for 10 minutes followed by 40 repetitive
cycles of 95uC for 15 sec, 60uC for 1 min. As a normalization
control for RNA loading, parallel reactions in the same multiwell
plate were performed using glyceraldehyde-3-phosphate dehydro-
genase (GAPDH).
Quantification of gene amplification following RT-PCR was
made by determining the threshold cycle (CT) number for SYBR
Green fluorescence within the geometric region of the semi-log
plot generated during PCR. Within this region of the amplification
curve, each difference of one cycle is equivalent to a doubling of
the amplified product of the PCR. The relative quantification of
target gene expression across treatments was evaluated using the
comparative CT method. The DCT value was determined by
subtracting the GAPDH CT value for each sample from the target
CT value of that sample. Calculation of DDCT involved using the
highest sample DCT value (i.e., sample with the lowest target
expression) as an arbitrary constant to subtract from all other DCT
sample values. Fold changes in the relative gene expression of
target was determined by evaluating the expression, 2
2DD CT. The
data was analyzed using using RealTime StatMiner
TM package, a
bioinformatics software developed by integromics, on Spotfire
DecisionSite.
Supporting Information
Figure S1 Percentages of B cells in the intestinal lamina
propria prior to and at 21 and 90d after SIV infection.
The average CD20
+ B cell percentages (dotted line) at 21 and 90d
after infection were not statistically different from the pre-infection
time point (p.0.05).
(TIF)
Table S1 The full list of differentially expressed genes
showing statistical significance at 21 days after SIV
infection with their affymetrix IDs, gene and functional
annotation. Tab 1: Up in 21d PI, Tab 2: Down in 21d PI, Tab 3:
Up in 21d compared to 90d PI.
(XLSX)
Table S2 The full list of differentially expressed genes
showing statistical significance at 90 days after infection
with their affymetrix IDs, gene and functional annota-
tion. Tab 1: Up in 90d PI, Tab 2: Down in 90d PI, Tab 3: Up in
90d compared to 21d PI.
(XLSX)
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